Antimicrobial photodynamic therapy: Applications beyond skin cancer

Journal of Drugs in Dermatology

Volumn 13, Issue 5, 2014, Pages 624-629

  Krausz, Aimee ^a   Friedman, Adam J ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3,7 BIS(N,N DIBUTYLAMINO)PHENOTHIAZIN 5 IUM BROMIDE; AMINOLEVULINIC ACID; AMINOLEVULINIC ACID METHYL ESTER; ANTHRAQUINONE DERIVATIVE; BACTERIOCHLORIN; CURCUMIN; CURCUMINOID DERIVATIVE; HYPERICIN; HYPOCHLORITE; INDOCYANINE GREEN; INDOLEACETIC ACID; INDUCIBLE NITRIC OXIDE SYNTHASE; METHYLENE BLUE; MYELOPEROXIDASE; NITRIC OXIDE; PHENOTHIAZINE DERIVATIVE; PHOTOSENSITIZING AGENT; PHTHALOCYANINE DERIVATIVE; PHTHALOCYANINE ZINC; PORPHYRIN DERIVATIVE; PPA 904; PROTOPORPHYRIN; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; RLP 068; SINGLET OXYGEN; SUPEROXIDE; TOLONIUM CHLORIDE; UNCLASSIFIED DRUG;

ACNE; ANTIBIOTIC RESISTANCE; ANTIMICROBIAL ACTIVITY; BIOSYNTHESIS; DRUG PENETRATION; EROSION; ERYTHEMA; HUMAN; HYPERPIGMENTATION; LEG ULCER; LIGHT EMITTING DIODE; LIGHT EXPOSURE; ONYCHOMYCOSIS; OXIDATIVE STRESS; PAIN; PHOTODYNAMIC THERAPY; PULSED DYE LASER; PUSTULE; SHORT SURVEY; SKIN CANCER; SKIN EDEMA; SKIN INFECTION; SKIN LEISHMANIASIS; TREATMENT INDICATION; TREATMENT OUTCOME; VERRUCA VULGARIS; WOUND INFECTION; IMMUNOLOGY; INFECTION; INNATE IMMUNITY; METABOLISM; PHOTOCHEMOTHERAPY; PROCEDURES;

HUMANS; IMMUNITY, INNATE; INFECTION; OXIDATIVE STRESS; PHOTOCHEMOTHERAPY; REACTIVE OXYGEN SPECIES;

EID: 84900565907     PISSN: 15459616     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (69)

1. Valansever F, De Melo WC, Avci P et al. Antimicrobial strategies centered around reactive oxygen species-bactericidal antibiotics, photodynamic therapy, and beyond. FEMS Microbiol Rev. Nov. 2013;37(6):955-989.
2. Kalyanaraman B, Teaching the basics of redox biology to medical and graduate students: Oxidants, antioxidants and disease mechanisms. Redox Biol. 2013;1(1):244-257.
3. Babilas P, Schreml S, Landthaler M, Szeimies RM. Photodynamic therapy in dermatology: state-of-the-art. Photodermatol Photoimmunol Photomed. Jun. 2010;26(3):118-132.
4. Dai T, Huang YY Hamblin MR. Photodynamic therapy for localized infections-state of the art. Photodiagnosis Photodyn Ther. Sep-Dec. 2009:6(3-4):170-188.
5. Jori G, Fabris C, Soncin M et al. Photodynamic therapy in the treatment of microbial infections: basic principles and perspective applications. Lasers Surg Med. Jun. 2006;38(5):468-481.
6. Nitzan Y, Gutterman M, Malik Z, Ehrenberg B. Inactivation of gram-negative bacteria by photosensitized porphyrins. Photochem Photobiol. Jan 1992;55(1):89-96.
7. Bertoloni G, Rossi F Valduga G, Jori G, Van Lier J. Photosensitizing activity of water- and lipid-soluble phthalocyanines on Escherichia coli. FEMS Microbiol Lea. Sep. 1 1990:59(1-2):149-155.
8. Ortel B, Calzavara-Pinton P Advances in photodynamic therapy. A review. G Ital Dermatol Venereol. Aug. 2010;145(4):461-475.
9. Morton CA, Szeimies RM, Sidoroff A, Braathen LR. European guidelines for topical photodynamic therapy pan 2: emerging indications-field cancelation, photorejuvenation and inflammatory/infective dermatoses. J Eur Acad Dermatol Venereol. Jun. 2013;27(6):672-679.
10. Ormond AB, Freeman HS. Dye sensitizers for photodynamic therapy. Materials (Basel). 2013;6:817-840.
11. Peng Q, Soler AM, Warloe T, Nesland JM, Giercksky KE. Selective distribution of porphyrins in skin thick basal cell carcinoma after topical application of methyl 5-aminolevulmate. J Photochem Photobiol B. Sep. 15 2001;62(3):140-145.
12. Fritsch C. Homey B. Stahl W, Lehmann P, Ruzicka T, Sies H. Preferential relative porphyrin enrichment in solar keratoses upon topical application of delta-aminolevulinic acid methylester. J Photochem Photobiol. Aug. 1998;68(2):218-221.
13. Moloney FJ, Collins P. Randomized, double-blind, prospective study to compare topical 5-aminolaevulinic acid methylester with topical 5-aminolaevulinic acid photodynamic therapy for extensive scalp actinic keratosis. Brit J Dermatol. Jul. 2007;157(1):87-91.
14. Juzeniene A, Juzenas P, Ma LW, Lani V, Moan J. Topical application of 5-aminolaevulmicacid, methyl 5-aminolaevulinate and hexyl 5-aminolaevulinate on normal human skin. Brit J Dermatol. Oct. 2006;155(4):791-799.
15. Fotinos N, Campo MA, Popowycz F Gurny R, Lange N. 5-Ammolevulinic acid derivatives in photomedicine: Characteristics, application and perspectives. J Photochem Photobiol. Jul-Aug. 2006;82(4):994-1015.
16. Arits AH. Van De Weert MM, Nelemans PJ, Kelleners-Smeets NW. Pain during topical photodynamic therapy: uncomfortable and unpredictable. J Eur Acad Dermatol Venereol. Dec. 2010;24(12):1452-1457
17. Halldin CB, Gillstedt M, Paoli J, Wennberg AM, Gonzalez H. Predictors of pain associated with photodynamic therapy: a retrospective study of 658 treatments. Acta Dermato Venereology. Sep. 2011;91(5):545-551.
18. Sandberg C, Stenquist B, Rosdahl I et al. Important factors for pain during photodynamic therapy for actinic keratosis. Acta Dermato Venereologies. 2006;86(5):404-108.
19. Calzavara-Pinton PG, Rossi MT, Sala R. A retrospective analysis of real-life practice of off-label photodynamic therapy using methyl aminolevulinate (MAL-PDT) in 20 Italian dermatology departments. Part 2: oncologic and infectious indications. Photochem Photobiol Sci. Jan 2013;12(1):158-165.
20. Sakamoto FH. Torezan L, Anderson RR. Photodynamic therapy for acne vulgaris: a critical review from basics to clinical practice: part II. Understanding parameters for acne treatment with photodynamic therapy. J Am Acad Dermatol. Aug. 2010;63(2):195-211; quiz 211-192.
21. Taylor MN, Gonzalez ML. The practicalities of photodynamic therapy in acne vulgaris. Brit J Dermatol. Jun. 2009;160(6):1140-1148.
22. Ashkenazi H, Malik Z, Harth Y, Nitzan Y. Eradication of Propionibacterium acnes by its endogenic porphyrins after illumination with high intensity blue light. FEMS Immunol Med Microbiol. Jan 21 2003;35(1):17-24.
23. Divaris DX, Kennedy JC, Pottier RH. Phototoxic damage to sebaceous glands and hair follicles of mice after systemic administration of 5-aminolevulinic acid correlates with localized protoporphyrin IX fluorescence. Am J Pathol. Apr. 1990;136(4):891-897.
24. Degitz K. Phototherapy, photodynamic therapy and lasers in the treatment of acne. J Dtsch Dermatol Ges. Dec. 2009;7(12):1048-1054.
25. Wiegell SR, Wulf HC. Photodynamic therapy of acne vulgaris using methyl aminolaevulinate: a blinded, randomized, controlled trial. Brit J Dermatol. May 2006;154(5):969-976.
26. Gold MH, Biron JA, Boring M, Bridges TM, Bradshaw VL. Treatment of moderate to severe inflammatory acne vulgaris: photodynamic therapy with 5-aminolevulinic acid and a novel advanced fluorescence technology pulsed light source. J Drugs Dermatol. Mar. 2007;6(3):319-322.
27. Haedersdal M, Togsverd-Bo K, Wiegell SR, Wulf HC. Long-pulsed dye laser versus long-pulsed dye laser-assisted photodynamic therapy for acne vulgaris: A randomized controlled trial. J Am Acad Dermatol. Mar. 2008;58(3):387-394.
28. Hong SB, Lee MH. Topical aminolevulinic acid-photodynamic therapy for the treatment of acne vulgaris. Photodermatol Photoimmunol Photomed. Dec. 2005;21(6):322-325.
29. Horfelt C, Funk J, Frohm-Nilsson M, Wiegleb Edstrom D, Wennberg AM. Topical methyl aminolaevulinate photodynamic therapy for treatment of facial acne vulgaris: results of a randomized, controlled study. Brit J Dermatol. Sep. 2006;155(3):608-613.
30. Jang MS, Doh KS, Kang JS, Jeon YS, Suh KS, Kim ST. A comparative splitface study of photodynamic therapy with indocyanine green and indole-3-acetic acid for the treatment of acne vulgaris. Brit J Dermatol. Nov. 2011;165(5):1095-1100.
31. Na Jl. Kim SY, Kim JH. Youn SW, Huh CH, Park KC. Indole-3-aceiic acid: a potential new photosensitizer for photodynamic therapy of acne vulgaris. Lasers Surg Med. Mar. 2011;43(3):200-205.
32. Huh SY, Na Jl, Huh CH, Park KC. The effect of photodynamic therapy using indole-3-acetic Acid and green light on acne vulgaris. Annals of Dermatol. Feb. 2012;24(1):56-60.
33. Kim BJ, Lee HG, Woo SM, Youn Jl, Sun DH. Pilot study on photodynamic therapy for acne using indocyanine green and diode laser. J Dermatol. Jan 2009;36(1):17-21.
34. Vecchio D. Dai T, Huang L, Fantetti L, Roncucci G, Hamblin MR. Antimicrobial photodynamic therapy with RLP068 kills methicillin-resistant Staphylococcus aureus and improves wound healing in a mouse model of infected skin abrasion PDT with RLP068/CI in infected mouse skin abrasion. J Biophotonics. Sep. 2013;6(9):733-742.
35. Hamblin MR. O'Donnell DA, Murthy N, Contag CH, Hasan T. Rapid control of wound infections by targeted photodynamic therapy monitored by in vivo bioluminescence imaging. Photochem Photobiol. Jan 2002;75(1):51-57
36. Gad F Zahra T, Francis KP Hasan T Hamblin MR. Targeted photodynamic therapy of established soft-tissue infections in mice. Photochem Photobiol Sci. May 2004;3(5):451-458.
37. Wong XW, Wang YY, Sheu HM, Chuang YC. Bactericidal effects of toluidine blue-mediated photodynamic action on Vibrio vulnificus. Antimicrob Agents Chemother. Mar. 2005;49(3):895-902.
38. Brown S. Clinical antimicrobial photodynamic therapy: phase II studies in chronic wounds. J Natl Compr Cane Netw. Oct. 1 2012:10 Suppl 2:S80-83.
39. Mannucci E, Genovese S, Monami M, et al. Photodynamic topical antimicrobial therapy for infected foot ulcers in patients with diabetes: a randomized, double-blind, placebo-controlled study-the D. A. N. XE (Diabetic ulcer Antimicrobial NewXopical treatment Evaluation) study. Acta Diabetol. Dec. 19 2013.
40. Sperandio FF, Simoes A, Aranha AC, Correa L, Orsini Machado De Sousa SC. Photodynamic therapy mediated by methylene blue dye in wound healing. Photomed Laser Surg. Oct. 2010;28(5):581-587
41. Hamblin MR, Zahra T, Contag CH, McManus AT, Hasan T. Optical monitoring and treatment of potentially lethal wound infections in vivo. J Infect Dis. Jun. 1 2003:187(11):1717-1725.
42. Morley S, Griffiths J, Philips G et al. Phase Na randomized, placebo-controlled study of antimicrobial photodynamic therapy in bacterially colonized, chronic leg ulcers and diabetic foot ulcers: a new approach to antimicrobial therapy. Brit J Dermatol. Mar. 2013;168(3):617-624.
43. Mills SJ, Farrar MD, Ashcroft GS, Griffiths CE, Hardman MJ, Rhodes LE. Topical PDT following excisional wounding of human skin increases production of TGF-beta3, MMP-1 and MMP-9 with associated improvement in dermal matrix organisation. Brit J Dermatol. Jan 28 2014.
44. Garcia VG, De Lima MA, Okamoto T et al. Effect of photodynamic therapy on the healing of cutaneous third-degree-burn: histological study in rats. Lasers Med Sci. Mar. 2010;25(2):221-228.
45. Stender IM, Na R, Fogh H, Gluud C, Wulf HC. Photodynamic therapy with 5-aminolaevulinic acid or placebo for recalcitrant foot and hand warts: randomised double-blind trial. Lancet. Mar. 18 2000;355(9208):963-966.
46. Smucler R, Jatsova E. Comparative study of aminolevulic acid photodynamic therapy plus pulsed dye laser versus pulsed dye laser alone in treatment of viral warts. Photomed Laser Surg. Apr. 2005;23(2):202-205.
47. Ohtsuki A, Hasegawa T, Hirasawa Y Xsuchihashi H, Ikeda S. Photodynamic therapy using light-emitting diodes for the treatment of viral warts. J Dermatol. Oct. 2009;36(10):525-528.
48. Schroeter CA, Kaas L, Waterval JJ, Bos PM, Neumann HA. Successful treatment of periungual warts using photodynamic therapy: a pilot study. Eur Acad Dermatol Venereol. Oct. 2007;21(9):1170-1174.
49. Mizuki D, Kaneko T, Hanada K. Successful treatment of topical photodynamic therapy using 5-aminolevulinic acid for plane warts. Brit J Dermatol. Nov. 2003;149(5):1087-1088.
50. Lu YG, Wu JJ, He Y, Yang HZ, Yang YD. Efficacy of topical aminolevulinic acid photodynamic therapy for the treatment of verruca planae. Photomed Laser Surg. Aug. 2010;28(4):561-563.
51. Fehr MK, Hornung R, Degen A et al. Photodynamic therapy of vulvar and vaginal condyloma and intraepithelial neoplasia using topically applied 5-aminolevulinic acid. Lasers Surg Med. 2002;30(4):273-279.
52. Stefanaki IM, Georgiou S, Xhemelis GC, Vazgiouraki EM, Xosca AD. In vivo fluorescence kinetics and photodynamic therapy in condylomata acuminata. Brit J Dermatol. Nov. 2003;149(5):972-976.
53. Herzinger T, Wienecke R, Weisenseel P et al. Photodynamic therapy of genital condylomata in men. Clin Exp Dermatol. Jan 2006;31(1):51-53.
54. Chen K. Chang BZ, Ju M, Zhang XH, Gu H. Comparative study of photodynamic therapy vs C02 laser vaporization in treatment of condylomata acuminata: a randomized clinical trial. Brit J Dermatol. Mar. 2007:156(3):516-520.
55. Liang J, Lu XN, Xang H, Zhang Z, Fan J, Xu JH. Evaluation of photodynamic therapy using topical aminolevulinic acid hydrochloride in the treatment of condylomata acuminata: a comparative, randomized clinical trial. Photodermatol Photoimmunol Photomed. Dec. 2009;25(6):293-297.
56. Szeimies RM, Schleyer V, Moll I. Stocker M, Landthaler M, Karrer S. Adjuvant photodynamic therapy does not prevent recurrence of condylomata acuminata after carbon dioxide laser ablation-A phase III, prospective, randomized, bicentric, double-blind study. Dermatol Surg. May 2009;35(5):757-764.
57. Van Der Snoek EM, Robinson DJ, Van Hellemond JJ, Neumann HA. A review of photodynamic therapy in cutaneous leishmaniasis. Eur Acad Dermatol Venereol. Aug. 2008;22(8):918-922.
58. Gardlo K, Horska Z, Enk CD et al. Treatment of cutaneous leishmaniasis by photodynamic therapy. J Am Acad Dermatol. Jun. 2003;48(6):893-896.
59. Sohl S, Kauer F Paasch U, Simon JC. Photodynamic treatment of cutaneous leishmaniasis. J Dtsch Dermatol Ges. Feb. 2007;5(2):128-130.
60. Ghaffarifar F Jorjani O, Mirshams M et al. Photodynamic therapy as a new treatment of cutaneous leishmaniasis. East Mediterr Health J. Nov. 2006;12(6):902-908.
61. Enk CD, Fritsch C, Jonas F et al. Treatment of cutaneous leishmaniasis with photodynamic therapy. Arch Dermatol. Apr. 2003;139(4):432-434.
62. Asilian A, Davami M. Comparison between the efficacy of photodynamic therapy and topical paromomycin in the treatment of Old World cutaneous leishmaniasis: a placebo-controlled, randomized clinical trial. Clin Exp Dermatol. Sep. 2006;31(5):634-637
63. Evangelou G, Krasagakis K, Giannikaki E, Kruger-Krasagakis S, Tosca A. Successful treatment of cutaneous leishmaniasis with intralesional aminolevulinic acid photodynamic therapy. Photodermatol Photoimmunol Photomed. Oct. 2011:27(5):254-256.
64. Kosaka S, Akilov OE, O'Riordan K, Hasan X A mechanistic study of deltaaminolevulinic acid-based photodynamic therapy for cutaneous leishmaniasis. J Invest Dermatol. Jun. 2007;127(6):1546-1549.
65. Calzavara-Pmton P, Rossi MT Sala R, Venturini M. Photodynamic antifungal chemotherapy. Photochem Photobiol. May-Jun. 2012;88(3):512-522.
66. Ortiz AE, Avram MM, Wanner MA. A review of lasers and light for the treatment of onychomycosis. Lasers Surg Med. Dec. 24 2013.
67. Piraccini BM, Rech G, Xosti A. Photodynamic therapy of onychomycosis caused by Xrichophyton rubrum. J Am Acad Dermatol. Nov. 2008:59 (5 Suppl):S75-76.
68. Watanabe D, Kawamura C, Masuda Y, Akita Y, Tamada Y, Matsumoto Y. Successful treatment of toenail onychomycosis with photodynamic therapy. Arch Dermatol. Jan 2008;144(1):19-21.
69. Sotiriou E, Koussidou-Eremonti T Chaidemenos G, Apalla Z, Loannides D. Photodynamic therapy for distal and lateral subungual toenail onychomycosis caused by Xrichophyton rubrum: Preliminary results of a single-centre open trial. Acta Derm Venereol. Mar. 2010;90(2):216-217